Medicare-certified home health agencies, which are key to allowing older adults to age in place, are increasingly going through ownership changes, raising concerns about health care spending, workforce, and quality of care, according to a study by UTHealth Houston.
Researchers at UTHealth Houston have been awarded an $8.1 million grant by the National Institutes of Health (NIH) to examine skeletal stem cells as potential drivers of craniofacial bone diseases and deformities. The study is led by Noriaki Ono, DDS, PhD, associate professor of orthodontics, and diagnostic and biomedical sciences at UTHealth Houston School of Dentistry.
Improving clinical outcomes in stroke patients by closing a gap between successful re-opening of a blocked vessel through endovascular surgery and a reduction of disability is the focus of a $2.5 million grant awarded to UTHealth Houston researchers.
An intervention study to improve outcomes for cancer survivors and enhance primary care capacity, funded with a $4.8 million grant from the National Cancer Institute, will be implemented by UTHealth Houston researchers in partnership with eight Texas primary care community health centers that treat under- and uninsured patients.
UTHealth Houston is the first institution in Houston to administer an FDA-approved drug, Kisunla (donanemab-azbt), for the treatment of early symptomatic Alzheimer’s disease.
Findings of a study on a novel and minimally invasive laser therapy for patients with drug-resistant epilepsy caused by periventricular nodular heterotopia (PNVH) have been published by UTHealth Houston researchers in American Neurological Association’s Annals of Neurology.
Studies by researchers at UTHealth Houston seeking to understand the underlying pathology of Alzheimer’s disease in order to discover new pathways to treatment have earned multiple awards totaling $3.5 million from the Texas Alzheimer’s Research and Care Consortium (TARCC).
UTHealth Houston and The Ocean Corporation are collaborating on UTHealth Houston’s Space Medicine Training Fellowship program, which now includes a two-week intensive training focused on hyperbaric technologies and analog environments akin to those astronauts experience during extravehicular activities (EVAs), or space walks.
UTHealth Houston has enrolled the first patient in the Southeastern United States into a national Phase I/II clinical trial testing whether a neural cell therapy product can help inhibit the abnormal electrical activity that leads to an epileptic seizure.
Building on the momentum of Cizik School of Nursing’s growing portfolio of studies funded by the National Institutes of Health, the institute will provide key resources that nurse scientists need to advance meaningful programs of research.
Cardiovascular health behaviors and overall cardiovascular health were directly associated with adolescent brain development and cognitive function, according to UTHealth Houston research published recently in the journal Mental Health and Physical Activity.
UTHealth Houston and OpenAI have announced a first-of-its-kind collaboration in the United States, marking the integration of AI technology into health care and education while protecting privacy.
A modern education space that is inclusive, safe, flexible, and environmentally conscious will be unveiled today as the new home of the UTHealth Houston School of Public Health in Austin.
Avian influenza A(H5N1) virus, which spread to cattle and infected 14 people this year, was detected using virome sequencing in the wastewater of 10 Texas cities by researchers at UTHealth Houston and Baylor College of Medicine.
Large-scale testing of self-managed auricular point acupressure for non-pharmaceutical pain management in rural communities is the focus of a new federal grant awarded to researchers with Cizik School of Nursing at UTHealth Houston.
A five-year, $5 million grant will allow researchers from UTHealth Houston and The University of Texas at Austin to test how community-level interventions can improve health and reduce disparities in low-income communities in Central Texas.
Genetic variants linked to a rare form of bicuspid aortic valve disease that affects young adults and can lead to dangerous and potentially life-threatening aortic complications have been identified by researchers at UTHealth Houston.
The only Injury Control Research Center in Texas has been established by the Centers for Disease Control and Prevention at UTHealth Houston in partnership with Baylor College of Medicine.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right